Johnson & Johnson Company News

Johnson & Johnson | History, Products, & Controversies - Encyclopedia Britannica

Johnson & Johnson | History, Products, & Controversies Encyclopedia Britannica

Johnson & Johnson Bumps Up Guidance as Sales Rise - WSJ

Johnson & Johnson Bumps Up Guidance as Sales Rise WSJ

Johnson & Johnson (JNJ) Stock Faces Margin Squeeze As Q2 Net Profitability Undercuts Bullish Narrative - simplywall.st

Johnson & Johnson (JNJ) Stock Faces Margin Squeeze As Q2 Net Profitability Undercuts Bullish Narrative simplywall.st

Johnson & Johnson (NYSE:JNJ) Shares Up 1.2% - Here's What Happened - MarketBeat

Johnson & Johnson (NYSE:JNJ) Shares Up 1.2% - Here's What Happened MarketBeat

Johnson and Johnson Earnings Report | 2026 Q2 Infographic - Johnson & Johnson

Johnson and Johnson Earnings Report | 2026 Q2 Infographic Johnson & Johnson

Could J&J Hit US$100bn Annual Revenue for the First Time? - Healthcare Digital

Could J&J Hit US$100bn Annual Revenue for the First Time? Healthcare Digital

Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain - BioSpace

Amid $55B US manufacturing push, J&J turns to streamlining its pharma supply chain BioSpace

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit - CNBC

J&J quarterly earnings beat Wall Street estimates on strength of medicines unit CNBC

Johnson & Johnson CFO Says Guidance Hike Is Just the Start - Barron's

Johnson & Johnson CFO Says Guidance Hike Is Just the Start Barron's

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain - Manufacturing Chemist

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain Manufacturing Chemist

J&J misses company expectations for cardiovascular in Q2 - MedTech Dive

J&J misses company expectations for cardiovascular in Q2 MedTech Dive

Johnson & Johnson posts Q2 2026 earnings beat on medicines unit strength - qz.com

Johnson & Johnson posts Q2 2026 earnings beat on medicines unit strength qz.com

Is Johnson & Johnson a Buy After Its Latest Earnings Report? - The Motley Fool

Is Johnson & Johnson a Buy After Its Latest Earnings Report? The Motley Fool

Johnson & Johnson MedTech sales grow 4.5% in Street-beating Q2, ups guidance - MassDevice

Johnson & Johnson MedTech sales grow 4.5% in Street-beating Q2, ups guidance MassDevice

Johnson & Johnson $JNJ Shares Bought by Livforsakringsbolaget Skandia Omsesidigt - MarketBeat

Johnson & Johnson $JNJ Shares Bought by Livforsakringsbolaget Skandia Omsesidigt MarketBeat

Johnson & Johnson $JNJ Shares Acquired by MASTERINVEST Kapitalanlage GmbH - MarketBeat

Johnson & Johnson $JNJ Shares Acquired by MASTERINVEST Kapitalanlage GmbH MarketBeat

Johnson & Johnson (NYSE:JNJ) Given Buy Rating at Guggenheim - MarketBeat

Johnson & Johnson (NYSE:JNJ) Given Buy Rating at Guggenheim MarketBeat

Johnson & Johnson $JNJ Shares Acquired by First National Bank of Hutchinson - MarketBeat

Johnson & Johnson $JNJ Shares Acquired by First National Bank of Hutchinson MarketBeat

Rep. Thomas H. Kean, Jr. Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat

Rep. Thomas H. Kean, Jr. Sells Off Shares of Johnson & Johnson (NYSE:JNJ) MarketBeat

Hillsdale Investment Management Inc. Reduces Stock Holdings in Johnson & Johnson $JNJ - MarketBeat

Hillsdale Investment Management Inc. Reduces Stock Holdings in Johnson & Johnson $JNJ MarketBeat

Scotiabank Reaffirms Their Buy Rating on Johnson & Johnson (JNJ) - The Globe and Mail

Scotiabank Reaffirms Their Buy Rating on Johnson & Johnson (JNJ) The Globe and Mail

Johnson & Johnson Reports Strong Q2, Solid Growth in Vision Care - VisionMonday.com

Johnson & Johnson Reports Strong Q2, Solid Growth in Vision Care VisionMonday.com

Johnson & Johnson commits to $55B, 4-year US investment plan - Fox Business

Johnson & Johnson commits to $55B, 4-year US investment plan Fox Business

Avantax Planning Partners Inc. Reduces Stock Holdings in Johnson & Johnson $JNJ - MarketBeat

Avantax Planning Partners Inc. Reduces Stock Holdings in Johnson & Johnson $JNJ MarketBeat

The Real Engine Behind Johnson & Johnson Stock’s Next Climb - Trefis

The Real Engine Behind Johnson & Johnson Stock’s Next Climb Trefis

Rep. Thomas H. Kean, Jr. Unloads Shares of Johnson & Johnson (NYSE:JNJ) - MarketBeat

Rep. Thomas H. Kean, Jr. Unloads Shares of Johnson & Johnson (NYSE:JNJ) MarketBeat

J&J Aims To Be $100-Bn Company; Begins Supply-Chain Restructuring - DCAT Value Chain Insights

J&J Aims To Be $100-Bn Company; Begins Supply-Chain Restructuring DCAT Value Chain Insights

Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026? - The Motley Fool

Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026? The Motley Fool

Earnings call transcript: Johnson & Johnson tops Q2 2026 estimates and lifts outlook - Investing.com

Earnings call transcript: Johnson & Johnson tops Q2 2026 estimates and lifts outlook Investing.com

Johnson & Johnson Q2: Solid (If Not Spectacular) Performance Satisfies Wall Street (JNJ) - Seeking Alpha

Johnson & Johnson Q2: Solid (If Not Spectacular) Performance Satisfies Wall Street (JNJ) Seeking Alpha

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award - Business Wire

Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award Business Wire